WO2002096371A1 - Cosmetic compositions containing rosemary extract and dha - Google Patents

Cosmetic compositions containing rosemary extract and dha Download PDF

Info

Publication number
WO2002096371A1
WO2002096371A1 PCT/US2002/016766 US0216766W WO02096371A1 WO 2002096371 A1 WO2002096371 A1 WO 2002096371A1 US 0216766 W US0216766 W US 0216766W WO 02096371 A1 WO02096371 A1 WO 02096371A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
rosemary extract
dha
weight
skin
Prior art date
Application number
PCT/US2002/016766
Other languages
French (fr)
Inventor
Marina Sokolinsky
Asira Ostrovskaya
Peter A. Landa
Daniel H. Maes
Original Assignee
E-L Management Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E-L Management Corp. filed Critical E-L Management Corp.
Priority to US10/451,565 priority Critical patent/US7223382B2/en
Priority to JP2002592884A priority patent/JP4300034B2/en
Priority to CA002433343A priority patent/CA2433343C/en
Priority to EP02737222A priority patent/EP1395228A4/en
Publication of WO2002096371A1 publication Critical patent/WO2002096371A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Definitions

  • the invention relates to cosmetic compositions. More specifically, the invention relates to self-tanning cosmetic compositions.
  • the present invention relates to a cosmetic composition comprising DHA in combination with an effective amount of a rosemary extract or active component thereof.
  • a cosmetic composition is intended to encompass any composition containing DHA intended for topical application to the skin, which may also include compositions that are used in therapeutic applications, for example, in conjunction with PUVA therapy.
  • the invention also relates to a method of preventing or reducing the generation of malodor on the skin resulting from application of a DHA-containing self-tanner, comprising applying to the skin a composition comprising DHA combined with an effective amount of rosemary extract.
  • Rosemary extract is a natural and known material extracted from the rosemary plant, and having established properties as an antioxidant. However, notwithstanding its known properties, in the present case, where the problem seems not to arise in degradation of the formula, but rather due to a reaction on the skin about which very little is known, it was quite unexpected that the rosemary extract performed so remarkably. Rosemary extract is a generic term describing a number of different chemical compositions that may contain several different active components.
  • rosemary extract common components that are found in rosemary extract are carnosol, carnosic acid, methoxy camosic acid, rosmarinic acid, rosmanol and rosmaridiphenol, in different proportions depending on the individual extract.
  • Numerous rosemary extracts are available commercially, and any one can be used in the present invention.
  • particularly preferred for use is the "Guardian" rosemary extract available from Earth Supplied Products.
  • This extract contains, in a base of lecithin, acetylated hydrogenated vegetable glycerides and propylene glycol, an active rosemary extract, in an amount of from about 12-30%, containing a minimum of 5% phenolic diterpenes.
  • the active portion contains a minimum of 50%o carnosic acid, carnosol in an amount of 20-35%>, and methoxy carnosic acid in an amount of from about 5-
  • rosemary extract shall encompass not only a rosemary extract per se, but also a composition to which the individual active components, such as are noted above, are added to the composition individually, or in individual combinations, from synthetic or natural sources, either from rosemary or from starting material other than rosemary, in amounts equivalent to those described in the use of the rosemary extract.
  • the active rosemary extract can be used in the DHA formulation in an amount of from about 0.001 to about 50%> by weight of the total composition.
  • the extract is extremely efficacious, requiring only small amounts to achieve reduction in odor, so the preferred range of use of the extract is about 0.1 to about 10% by weight of the composition.
  • the extract can be added to any type of formulation in which DHA is ordinarily applied, for example, creams, lotions, sprays, sticks and the like, and may be aqueous, water and oil or anhydrous.
  • the amount of DHA employed will be in line with the typical use of this material, which is generally in the range of from about 1-10%.
  • Another unexpected result of the use of the rosemary extract is its lack of adverse effect on color development with DHA. DHA is a relatively unstable material, and is subject to alterations in its performance when in the presence of other incompatible materials.
  • rosemary extract has no adverse effect on the color development, and in some cases even seemed to improve it.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a topical composition comprising a malodor-reducing effective amount of a rosemary extract, or active fraction thereof, in combination with a self-tanning effective amount of DHA. The invention also provides a method of reducing the potential for malodor generation of a DHA composition comprising adding to the composition an effective amount of rosemary extract or active fraction thereof.

Description

COSMETIC COMPOSITIONS CONTALNLNG ROSEMARY EXTRACT AND DHA
Field of the Invention
The invention relates to cosmetic compositions. More specifically, the invention relates to self-tanning cosmetic compositions.
Background of the Invention
With sun exposure being recognized as a significant health risk, the desirability of sitting for hours to develop a deep tan has diminished considerably in recent years. However, the desire to have that bronze glow has not diminished in a large portion of the population. The solution for most prudent consumers is the use of self-tanning products. These products typically employ the compound dihydroxyacetone(DHA), which interacts with the proteins on the skin to produce a brown color approximating a sun-derived tan. In the early days of self- tanners, there were a number of problems which prevented widespread acceptance, the primary one being the unnatural orange color that would develop on some users. However, self-tanners have improved tremendously in recent years, and most products currently available produce natural and fairly long-lasting color on the user. There is one remaining issue with self-tanners that continues to reduce their acceptability to the consumer: after application, many users detect a malodor that lingers for up to 24 hours. The unpleasant odor apparently arises as a result of compounds generated on the skin upon application of the self- tanner. The only solution known to date is the incorporation of fragrance or oils that mask the odor to some extent; however, the addition of fragrance is not always an acceptable option to every product, and in any event does not address the root of the problem, i.e., neutralizing the compounds generated on the skin. To date, this problem continues to affect self-tanners, and therefore, may prevent their more frequent usage. The present invention now provides a solution for the odor generated upon application of the self-tanner to the skin.
Summary of the Invention
The present invention relates to a cosmetic composition comprising DHA in combination with an effective amount of a rosemary extract or active component thereof. As used herein, the term "cosmetic composition" is intended to encompass any composition containing DHA intended for topical application to the skin, which may also include compositions that are used in therapeutic applications, for example, in conjunction with PUVA therapy. The invention also relates to a method of preventing or reducing the generation of malodor on the skin resulting from application of a DHA-containing self-tanner, comprising applying to the skin a composition comprising DHA combined with an effective amount of rosemary extract.
Detailed Description of the Invention
It has been unexpectedly discovered that the addition of rosemary extract to compositions containing DHA will prevent or reduce the typical malodor associated with the application of DHA compositions to the skin. Rosemary extract is a natural and known material extracted from the rosemary plant, and having established properties as an antioxidant. However, notwithstanding its known properties, in the present case, where the problem seems not to arise in degradation of the formula, but rather due to a reaction on the skin about which very little is known, it was quite unexpected that the rosemary extract performed so remarkably. Rosemary extract is a generic term describing a number of different chemical compositions that may contain several different active components. Among the common components that are found in rosemary extract are carnosol, carnosic acid, methoxy camosic acid, rosmarinic acid, rosmanol and rosmaridiphenol, in different proportions depending on the individual extract. Numerous rosemary extracts are available commercially, and any one can be used in the present invention. However, particularly preferred for use is the "Guardian" rosemary extract available from Earth Supplied Products. This extract contains, in a base of lecithin, acetylated hydrogenated vegetable glycerides and propylene glycol, an active rosemary extract, in an amount of from about 12-30%, containing a minimum of 5% phenolic diterpenes. In particular, the active portion contains a minimum of 50%o carnosic acid, carnosol in an amount of 20-35%>, and methoxy carnosic acid in an amount of from about 5-
15%), with minor amounts of rosmanol, rosmarinic acid and rosmaridiphenol. It will be understood that the term "rosemary extract" as used herein shall encompass not only a rosemary extract per se, but also a composition to which the individual active components, such as are noted above, are added to the composition individually, or in individual combinations, from synthetic or natural sources, either from rosemary or from starting material other than rosemary, in amounts equivalent to those described in the use of the rosemary extract.
The active rosemary extract can be used in the DHA formulation in an amount of from about 0.001 to about 50%> by weight of the total composition. However, the extract is extremely efficacious, requiring only small amounts to achieve reduction in odor, so the preferred range of use of the extract is about 0.1 to about 10% by weight of the composition. The extract can be added to any type of formulation in which DHA is ordinarily applied, for example, creams, lotions, sprays, sticks and the like, and may be aqueous, water and oil or anhydrous. The amount of DHA employed will be in line with the typical use of this material, which is generally in the range of from about 1-10%. Another unexpected result of the use of the rosemary extract is its lack of adverse effect on color development with DHA. DHA is a relatively unstable material, and is subject to alterations in its performance when in the presence of other incompatible materials. However, surprisingly, rosemary extract has no adverse effect on the color development, and in some cases even seemed to improve it.
The invention will be further understood by reference to the following non-limiting examples.
EXAMPLES Example 1
Initial studies were performed to identify compounds which might assist in reducing the malodor associated with DHA application on the skin. A first attempt tested compounds generally known to have odor-reducing properties, namely, dipropylene glycol, zinc acetate, choline, and aloe vera gel. No consistent positive results were obtained with any of these compounds.
A secondary experiment was conducted on a new raw material: 'Guardian' Rosemary Extract produced by Earth Supplied Products. The influence of Rosemary Extract (RME) on odor formation on 14 panelists using aqueous solutions of DHA and Rosemary Extract was investigated. Color and odor were tested on the panelists to determine any differences in the reaction of DHA in the presence of Rosemary Extract.
Results and Discussions: I) Clinical Study: Applications of Aqueous Solutions of DHA alone and DHA with RME to the skin
In the presence of RME, significant odor improvement was observed on 13 / 14 panelists (0.25%> RME). One panelist did not produce any malodor when DHA was applied. The improvement in odor was most evident at 24 hours after the application to the skin.
Under these conditions we observed greater than 90% reduction in malodor formation. When the color development was compared between test and control compositions, we observed that in the presence of RME, no difference in color was evident. (In some cases, the color development was slightly improved) Therefore, while using RME significantly reduced the malodor - there was no inhibition of the DHA color reaction as was seen previously with other ingredients tested.
Example 2
The following illustrates a composition, a water and oil emulsion, of the invention: Material Weight %
Cyclomethicone 11.00
Cetyl Dimethicone copolyol 1.00
Cyclomethcone/PEG/PPG-18/18 dimethicone 5.00
Tocopheryl acetate 0.20
Polysilicone 7/cyclomethicone 1.50
Fragrance 0.40
Deionized water QS
DHA 4.00
Glycerin 8.00
Sodium chloride 0.80
Lactic acid 0.50
Pantethine 0.02
Cyclomethicone 2.00
Black Iron oxide 0.02
Iron oxide/alumina 0.38
Mica/titanium dioxide/iron oxides/ dimethicone 0.22
Mica/iron oxides 0.14
Preservative 0.50
Rosemary extract 0.25
Cyclomethicone .1.00 Cyclomethicone/dimethicone/vinyl dimethicone crosspolymer 3.50

Claims

What we claim is:
I . A cosmetic self-tanning composition comprising a malodor-reducing effective amount of a rosemary extract, or active fraction thereof, in combination with a self-tanning effective amount of DHA. 2. The composition of claim 1 comprising from about 0.0001 to about 50%) of a rosemary extract, and about 1 to about 10% of DHA.
3. The composition of claim 1 comprising from about 0.1 to about 10%> of rosemary extract.
4. The composition of claim 1 in which the rosemary extract comprises carnosol and carnosic acid. 5. The composition of claim 1 in which the rosemary extract comprises at least about 50% by weight carnosic acid.
6. The composition of claim 1 in which the rosemary extract comprises from about 20 to about 35 % by weight carnosol.
7. The composition of claim 1 in which the rosemary extract comprises from about 5 to about 15 %> by weight of methoxy carnosic acid.
8. A cosmetic composition comprising from about 1 to about 10% by weight of DHA, and about 0.1 to about 10%> by weight rosemary extract.
9. The composition of claim 8 in which the rosemary extract comprises at least about 50%> by weight of carnosic acid. 10. The composition of claim 9 in which the rosemary extract contains from about 20 to about 35% by weight of carnosol.
I I . The composition of claim 10 in which the rosemary extract contains from about 5 to about 15% by weight of methoxy carnosic acid.
12. A method of formulating a DHA-containing composition which upon application to skin generates little or no malodor, comprising adding to a composition containing DHA a malodor-reducing effective amount of a rosemary extract.
13. The method of claim 12 in which the amount of rosemary extract is from about .1 to about 10% by weight.
14. The method of claim 13 in which the rosemary extract contains carnosic acid in an amount of at least about 50% by weight.
15. The method of claim 14 in which the rosemary comprises from about 20 to about 35% by weight of carnosol.
16. The method of claim 15 in which the rosemary extract comprises from about 5 to about 15%) by weight methoxy carnosic acid.
17. A method of reducing or preventing the development of malodor on the skin associated with DHA-containing compositions, comprising applying to the skin the composition of claim 1.
18. A method of reducing or preventing the development of malodor on the skin associated with DHA-containing compositions, comprising applying to the skin the composition of claim 5.
19. A method of reducing or preventing the development of malodor on the skin associated with DHA-containing compositions, comprising applying to the skin the composition of claim 8. 20. A method of reducing or preventing the development of malodor on the skin associated with DHA-containing compositions, comprising applying to the skin the composition of claim 11.
PCT/US2002/016766 2001-05-29 2002-05-29 Cosmetic compositions containing rosemary extract and dha WO2002096371A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/451,565 US7223382B2 (en) 2002-05-29 2002-05-29 Cosmetic compositions containing rosemary extract and DHA
JP2002592884A JP4300034B2 (en) 2001-05-29 2002-05-29 Cosmetic composition containing rosemary extract and DHA
CA002433343A CA2433343C (en) 2001-05-29 2002-05-29 Cosmetic compositions containing rosemary extract and dha
EP02737222A EP1395228A4 (en) 2001-05-29 2002-05-29 Cosmetic compositions containing rosemary extract and dha

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29409301P 2001-05-29 2001-05-29
US60/294,093 2001-05-29

Publications (1)

Publication Number Publication Date
WO2002096371A1 true WO2002096371A1 (en) 2002-12-05

Family

ID=23131844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/016766 WO2002096371A1 (en) 2001-05-29 2002-05-29 Cosmetic compositions containing rosemary extract and dha

Country Status (4)

Country Link
EP (1) EP1395228A4 (en)
JP (2) JP4300034B2 (en)
CA (1) CA2433343C (en)
WO (1) WO2002096371A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077327A1 (en) * 2004-02-11 2005-08-25 Beiersdorf Ag Cosmetic and dermatological self-tanning formulations comprising dihydroxyacetone and glycerin
WO2005102010A2 (en) * 2004-04-21 2005-11-03 The Procter & Gamble Company Personal care compositions that deposit sunless tanning benefit agents
WO2006007487A3 (en) * 2004-07-01 2006-08-17 E L Management Corp Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
WO2005102011A3 (en) * 2004-04-21 2007-06-14 Procter & Gamble Personal care compositions that deposit hydrophilic benefit agents
WO2007118565A1 (en) * 2006-04-13 2007-10-25 Merck Patent Gmbh Use of flavonoids
WO2008020058A2 (en) * 2006-08-17 2008-02-21 Technische Universität Dresden Use of monosaccharides or disaccharides for masking odours and method and composition for masking odours
KR100871962B1 (en) 2004-07-01 2008-12-08 이-엘 매니지먼트 코포레이션 Cosmetic compositions and methods containing a tanning agent and liposome-encapsulated ursolic acid
US8263058B2 (en) 2004-04-21 2012-09-11 The Procter & Gamble Company Personal care compositions that deposit hydrophilic benefit agents
WO2013156859A2 (en) * 2012-04-20 2013-10-24 Kao Corporation Self-tanning cosmetic

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4300034B2 (en) * 2001-05-29 2009-07-22 イーエルシー マネージメント エルエルシー Cosmetic composition containing rosemary extract and DHA
JP6960742B2 (en) * 2017-02-07 2021-11-05 サントリーホールディングス株式会社 Beer-taste beverages and their manufacturing methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827506A (en) * 1993-03-31 1998-10-27 Schering-Plough Healthcare Products, Inc. Sunless tanning method and apparatus
US6316012B1 (en) * 1992-09-01 2001-11-13 L'oreal Cosmetic or pharmaceutical composition comprising, in combination, a peroxidase and an anti-singlet oxygen agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57204278A (en) * 1981-06-11 1982-12-14 Lion Corp Preparation of deodorizing substance
JPS59103665A (en) * 1982-12-03 1984-06-15 ライオン株式会社 Deodorant
DE4441470A1 (en) * 1993-11-25 1995-06-01 Merck Patent Gmbh Skin colouring compsn. for durable, high intensity natural tan tones
JP3625976B2 (en) * 1997-01-30 2005-03-02 高砂香料工業株式会社 Deodorant composition
JPH1113150A (en) * 1997-06-23 1999-01-19 Nakamura:Kk Bond anchor method
JP4300034B2 (en) * 2001-05-29 2009-07-22 イーエルシー マネージメント エルエルシー Cosmetic composition containing rosemary extract and DHA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316012B1 (en) * 1992-09-01 2001-11-13 L'oreal Cosmetic or pharmaceutical composition comprising, in combination, a peroxidase and an anti-singlet oxygen agent
US5827506A (en) * 1993-03-31 1998-10-27 Schering-Plough Healthcare Products, Inc. Sunless tanning method and apparatus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1395228A4 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077327A1 (en) * 2004-02-11 2005-08-25 Beiersdorf Ag Cosmetic and dermatological self-tanning formulations comprising dihydroxyacetone and glycerin
WO2005102010A2 (en) * 2004-04-21 2005-11-03 The Procter & Gamble Company Personal care compositions that deposit sunless tanning benefit agents
US8263058B2 (en) 2004-04-21 2012-09-11 The Procter & Gamble Company Personal care compositions that deposit hydrophilic benefit agents
WO2005102010A3 (en) * 2004-04-21 2007-05-31 Procter & Gamble Personal care compositions that deposit sunless tanning benefit agents
WO2005102011A3 (en) * 2004-04-21 2007-06-14 Procter & Gamble Personal care compositions that deposit hydrophilic benefit agents
KR100871962B1 (en) 2004-07-01 2008-12-08 이-엘 매니지먼트 코포레이션 Cosmetic compositions and methods containing a tanning agent and liposome-encapsulated ursolic acid
AU2005262369B2 (en) * 2004-07-01 2008-08-28 E-L Management Corp. Cosmetic compositions and methods containing a tanning agent and liposome-encapsulated ursolic acid
WO2006007487A3 (en) * 2004-07-01 2006-08-17 E L Management Corp Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
WO2007118565A1 (en) * 2006-04-13 2007-10-25 Merck Patent Gmbh Use of flavonoids
WO2008020058A2 (en) * 2006-08-17 2008-02-21 Technische Universität Dresden Use of monosaccharides or disaccharides for masking odours and method and composition for masking odours
WO2008020058A3 (en) * 2006-08-17 2008-11-27 Univ Dresden Tech Use of monosaccharides or disaccharides for masking odours and method and composition for masking odours
WO2013156859A2 (en) * 2012-04-20 2013-10-24 Kao Corporation Self-tanning cosmetic
WO2013156859A3 (en) * 2012-04-20 2014-11-13 Kao Corporation Self-tanning cosmetic
AU2013250892B2 (en) * 2012-04-20 2017-05-04 Kao Corporation Self-tanning cosmetic

Also Published As

Publication number Publication date
JP4300034B2 (en) 2009-07-22
EP1395228A4 (en) 2004-10-13
JP2004520447A (en) 2004-07-08
CA2433343A1 (en) 2002-12-05
JP2007016045A (en) 2007-01-25
EP1395228A1 (en) 2004-03-10
CA2433343C (en) 2009-01-06

Similar Documents

Publication Publication Date Title
US5910311A (en) Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it
JP2007016045A (en) Cosmetic compositions containing rosemary extract and dha
US6641845B1 (en) Skin whitening composition comprising bearberry and tetrahydrocurcumin
US5256401A (en) Antibacterial antiplaque mouthwash composition
JP2502318B2 (en) Whitening cosmetics
US7223382B2 (en) Cosmetic compositions containing rosemary extract and DHA
JP2001131026A (en) Cosmetic for scalp and hair
JPH06227959A (en) Melanin formation inhibitor and skin cosmetic
JPH11269034A (en) Skin prepafation for external use for improving acne
US5942212A (en) Self tanning composition containing DHA and α hydroxy acids
AU7733401A (en) Method for promoting clear skin
CZ31798A3 (en) Cosmetic way of treating and prevention signs of skin ageing
US20230149274A1 (en) An antimicrobial composition for tackling malodour
JPS62267214A (en) Dermatic agent for external use
JP2001131025A (en) Cosmetic for scalp and hair
JP2001270828A (en) External preparation for prevention and therapy of vulgaris acne and cosmetic prepared by formulating the same
JPH072640A (en) External preparation for protecting ultraviolet disorder
JP2006315957A (en) Singlet oxygen scavenger and external preparation for skin using the same
JPH0193509A (en) Skin drug for external use
KR102419399B1 (en) Cica-care cream composition and manufacturing method thereof
JPH10273424A (en) Cosmetic for hair
JPS60188306A (en) Cosmetic
JP2003183113A (en) Composition for external use
JP2024138105A (en) Cosmetics
JP2003321340A (en) Cosmetic

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10451565

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002737222

Country of ref document: EP

Ref document number: 2433343

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002592884

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002737222

Country of ref document: EP